EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of anaplastic carcinoma of the thyroid Curative outcome with multimodality therapy



Treatment of anaplastic carcinoma of the thyroid Curative outcome with multimodality therapy



International Journal of Radiation Oncology Biology Physics 45(3 SUPPL ): 367-368




(PDF 0-2 workdays service: $29.90)

Accession: 035980941

Download citation: RISBibTeXText



Related references

Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients. RadioTherapy and Oncology 92(1): 100-104, 2009

Multimodality treatment in anaplastic giant cell thyroid carcinoma. Cancer 60(7): 1428-1431, 1987

Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery. Minerva Chirurgica 69(5): 261-269, 2015

The utility of multimodality imaging in anaplastic thyroid carcinoma. Thyroid 14(11): 981-982, 2005

Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103(7): 1330-1335, 2005

A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients. Journal of Endocrinological Investigation 23(11): 755-761, 2001

Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach. Anz Journal of Surgery 74(7): 559-562, 2004

The impact of prognostic factors and treatment on the outcome of anaplastic carcinoma of thyroid. EJC Supplements 1(5): S46, September, 2003

Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution. Journal of Surgical Oncology 106(8): 981-986, 2013

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 10(7): 587-594, 2000

Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. European Journal of Endocrinology 175(6): 521-529, 2016

Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients. Oncology 79(5-6): 400-408, 2011

Multimodality treatment of anaplastic thyroid cancer with nearly resolved effect. Journal of the Formosan Medical Association 114(9): 897-898, 2016

Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. Journal of Clinical Pathology 67(2): 125-133, 2014

Anaplastic Thyroid Carcinoma: Treatment in the Age of Molecular Targeted Therapy. Journal of Oncology Practice 12(6): 511-518, 2016